STAT

What’s in the House’s bills to address the opioid crisis — and what’s not

The House is expected to finish its opioids work this week. Here’s a look at what’s in the bills, and which proposals or policy ideas didn’t make the cut.
House Majority Leader Kevin McCarthy, Speaker of the House Paul Ryan, and House Energy and Commerce Committee Chairman Greg Walden, confer during a news conference in Washington on opioid addiction on June 13.

WASHINGTON — The House spent much of the last two weeks passing dozens of bills aimed at addressing the opioid crisis, an effort top lawmakers from both parties have long identified as a priority.

Many are consensus proposals, though a few have generated controversy. Some are substantial in their scope, though many fund pilot programs or studies, or enact grants for which funding will expire within years.

Outside experts, while applauding Congress for its focus on the issue, say they believe the current package fails to match the scope of the current crisis.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT1 min read
Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

Related